| Structure |
Chemical Name |
CAS |
MF |
 |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
 |
Ezetimibe Impurity 33 |
|
|
 |
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
|
|
Vonoprazan Impurity U4 |
|
|
 |
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
|
|
Parecoxib SodiuM iMpurity 37 |
|
|
![(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound](/CAS/20200611/GIF/105834-21-7.gif) |
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
 |
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
 |
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
|
|
Tenofovir Impurity 71 |
|
|
 |
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
 |
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
![Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod](/CAS/20210111/GIF/2243233-98-7.gif) |
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod |
2243233-98-7 |
C46H55NO14 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](/CAS/20200401/GIF/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
 |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](/CAS/20200401/GIF/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
|
|
Elagolix Sodium impurity5 |
|
|
|
|
Tadalafil Impurity 46 |
|
|
 |
(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
|
cefdinir |
|
|
 |
1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl- |
91639-43-9 |
C12H15N |
|
|
(E)-8-(3,4-dimethoxystyryl) |
|
|
|
|
(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol |
|
|
|
|
Cefdinir CP Impurity B |
|
|
 |
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
|
|
Fluconazole Impurity 2 |
|
|
|
|
Imatinib EP Impurity D Chloride |
|
|
|
|
Favipiravir Impurity |
|
|
 |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
|
|
Adsorption of hydrogen sulfide Adsorption of impurities in water filter material |
|
|
 |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
 |
2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl- 1,3-dioxan-4-yl)acetic acid |
775571-58-9 |
C9H15ClO4 |
|
|
Ruxolitinib Impurity 1 |
|
|
|
|
Cefradine Impurity L |
|
|
 |
(8beta)-10methoxy-6-dimethylergoline-8-methanol-5-bromo-3-pyridinecarboxylate(ester) |
35264-46-1 |
C23H24BrN3O3 |
|
|
Cephalexin Open-Ring Impurity |
|
|
|
|
Urapidil Impurity 18 |
|
|
|
|
Flomoxef Impurity IV |
|
|
|
|
Pitavastatin Impurity 54 Complete Set |
|
|
|
|
Cetrorelix Impurity 15 |
|
|
|
|
Brivaracetam Impurity 46 |
|
|
|
|
Peramivir Intermediate Impurity 38 |
|
|
|
|
Peramivir Guanidine Acetyl Positional Heterogeneous Impurities |
|
|
|
|
Ticagrelor impurity P drops |
|
|
|
|
3-[4-(2-isopropoxyethoxymethyl)phenoxy]-2-(isopropylamino)propan-1-ol |
|
|
|
|
Pemetrexed Disodium Impurity 31-40 |
|
|
|
|
Paclitaxel EP impurity drops |
|
|
|
|
Ticagrelor impurity PDD |
|
|
|
|
octahydro-1H,8H-dipyrazolo[1,2-a:1',2'-e][1,2,5,6]tetrazocine |
|
|
|
|
Bimatoprost Impurity S |
|
|
 |
BIS(2,6-DIPHENYLPHENOXY)NIOBIUM(V) CHLOR |
699012-35-6 |
C42H32Cl3NbO2 |
|
|
Brivaracetam Impurity 62 |
|
|
|
|
Lumateperone Impurity 4 |
|
|
|
|
SugammadexImpurity021 |
|
|
|
|
Pabocillin Impurity 28 |
|
|
|
|
Cefmetazole Sodium Impurity C |
|
|
|
|
Ceftriaxone Sodium Oxide Impurity |
|
|
|
|
2-[4-(Azidomethyl)phenyl]benzamide |
|
|
![1H-Benzimidazole-7-carboxylic acid, 1-[[2'-[4,5-dihydro-4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-oxo-1,2,4-oxadiazol-3-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-](/CAS/20210305/GIF/1985638-55-8.gif) |
1H-Benzimidazole-7-carboxylic acid, 1-[[2'-[4,5-dihydro-4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-oxo-1,2,4-oxadiazol-3-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy- |
1985638-55-8 |
C30H24N4O8 |
![2H-1,4-Benzoxazin-3(4H)-one, 8-[(1R)-2-bromo-1-hydroxyethyl]-6-(phenylmethoxy)-](/CAS/20210305/GIF/2248125-51-9.gif) |
2H-1,4-Benzoxazin-3(4H)-one, 8-[(1R)-2-bromo-1-hydroxyethyl]-6-(phenylmethoxy)- |
2248125-51-9 |
C17H16BrNO4 |
![Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]-](/CAS/20210305/GIF/158636-99-8.gif) |
Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]- |
158636-99-8 |
C10H17N3O2S |
|
|
Pemetrexed disodium Impurity 30 |
|
|
|
|
(S)-4,6,7,11-tetrahydroxy-9-(2-hydroxyacetyl)-7,8-dihydrotetracene-5,12-dione |
|
|
|
|
Ruxolitinib ImpurityABCDEFGHJKL |
|
|
|
|
Rosuvastatin Impurity 153 |
|
|
|
|
Rosuvastatin Impurity 138 |
|
|
|
|
Rosuvastatin Impurity 127 |
|
|
|
|
Oxacillin sodium EP impurity J |
|
|
|
|
Piperacillin Sodium EP Impurity P |
|
|
|
|
Ertapenem Impurity B(USP) |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2458312-06-4 |
C27H30N2O6 |
 |
15(R)-17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA |
41639-71-8 |
C23H32O5 |
|
|
(5R,6S)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
 |
Acetamide, N-(4-hydroxyphenyl)-N-nitroso- |
146897-60-1 |
C8H8N2O3 |
![3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-](/CAS/20210305/GIF/2402776-83-2.gif) |
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]- |
2402776-83-2 |
C16H17N7O2S |
|
|
Iohexol ImpuritiesE |
|
|
 |
TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE |
404958-08-3 |
C10H17ClO4 |
|
|
2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
|
|
|
|
8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-yl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine |
|
|
|
|
Bumetanide Photodegradable Impurity 16 |
|
|
|
|
Bisoprolol Impurity 47 |
|
|
|
|
Gadobutrol Impurity 11(Ammonium salt) |
|
|
|
|
Flomoxef Impurity F |
|
|
|
|
Tegoprazan Impurity 15 |
|
|
|
|
Nirmatrelvir Impurity 8 |
|
|
|
|
Nirmatrelvir Impurity 2 |
|
|
|
|
(5-(2-fluorophenyl)-1H-pyrrol-3-yl)methanamine hydrochloride |
|
|
|
|
Rocuronium Bromide Impurity 24 、25 |
|
|
|
|
Roxadustat Impurity 17 |
|
|
|
|
Perospirone Impurity 20 |
1002359-81-0 |
|
|
|
Dolutegravir Impurity 19 |
|
|
|
|
Cephalexin Impurity I |
|
|
|
|
Fondaparinux sodium impurity 6 |
|
|
|
|
Fondaparinux sodium impurity 2 |
|
|
|
|
Oxacillin sodium Impurity I |
|
|
|
|
Mixture of Cefoxitin Impurity E&F |
|
|
|
|
Revefenacin Impurity 22 |
|
|
|
|
Lasmiditan Impurity 7 |
|
|